Peng-fei Zhang

Chengdu, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Effects of Kuanxiong aerosol for preventing acute mountain sickness: an exploratory small-sample randomized, placebo-controlled trial.

Effects of Kuanxiong aerosol for preventing acute mountain sickness: an exploratory small-sample randomized, placebo-controlled trial.

Journal: Frontiers in physiology

Published: March 19, 2026

Immune checkpoint inhibitor-related thrombocytopenia: Current status and future perspectives.

Immune checkpoint inhibitor-related thrombocytopenia: Current status and future perspectives.

Journal: Critical reviews in oncology/hematology

Published: July 22, 2025

High-throughput strategies for monoclonal antibody screening: advances and challenges.

High-throughput strategies for monoclonal antibody screening: advances and challenges.

Journal: Journal of biological engineering

Published: February 25, 2025

Chemotherapy combined with cadonilimab (AK104) as neoadjuvant treatment for locally advanced gastric/gastro-oesophageal junction adenocarcinoma: study protocol for a single-arm, phase II clinical trial.

Chemotherapy combined with cadonilimab (AK104) as neoadjuvant treatment for locally advanced gastric/gastro-oesophageal junction adenocarcinoma: study protocol for a single-arm, phase II clinical trial.

Journal: BMJ open

Published: December 04, 2024

Noisy-Aware Unsupervised Domain Adaptation for Scene Text Recognition.

Noisy-Aware Unsupervised Domain Adaptation for Scene Text Recognition.

Journal: IEEE transactions on image processing : a publication of the IEEE Signal Processing Society

Published: November 12, 2024

Stress Echocardiography for Chronic Coronary Syndrome: Clinical Practice Guidelines (2023).

Stress Echocardiography for Chronic Coronary Syndrome: Clinical Practice Guidelines (2023).

Journal: Journal of geriatric cardiology : JGC

Published: July 01, 2024

SOX combined with tislelizumab and low-dose radiation therapy for the neoadjuvant treatment of locally advanced gastric/gastroesophageal junction adenocarcinoma: study protocol for a prospective, multicenter, single-arm, phase Ib/II clinical trial.

SOX combined with tislelizumab and low-dose radiation therapy for the neoadjuvant treatment of locally advanced gastric/gastroesophageal junction adenocarcinoma: study protocol for a prospective, multicenter, single-arm, phase Ib/II clinical trial.

Journal: Frontiers in immunology

Published: May 13, 2024

Targeting the gut microbiota to enhance the antitumor efficacy and attenuate the toxicity of CAR-T cell therapy: a new hope?

Targeting the gut microbiota to enhance the antitumor efficacy and attenuate the toxicity of CAR-T cell therapy: a new hope?

Journal: Frontiers in immunology

Published: December 27, 2023

Nivolumab plus chemotherapy versus chemotherapy alone as first-line treatment for advanced gastric, gastroesophageal junction, and esophageal adenocarcinoma: a cost-effectiveness analysis.

Nivolumab plus chemotherapy versus chemotherapy alone as first-line treatment for advanced gastric, gastroesophageal junction, and esophageal adenocarcinoma: a cost-effectiveness analysis.

Journal: Cost effectiveness and resource allocation : C/E

Published: September 18, 2022

Atezolizumab with chemotherapy in first-line treatment for metastatic urothelial cancer: a cost-effectiveness analysis.

Atezolizumab with chemotherapy in first-line treatment for metastatic urothelial cancer: a cost-effectiveness analysis.

Journal: Journal of comparative effectiveness research

Published: August 04, 2022

An integrated platform for Brucella with knowledge graph technology: From genomic analysis to epidemiological projection.

An integrated platform for Brucella with knowledge graph technology: From genomic analysis to epidemiological projection.

Journal: Frontiers in genetics

Published: June 29, 2022

Reversing chemokine/chemokine receptor mismatch to enhance the antitumor efficacy of CAR-T cells.

Reversing chemokine/chemokine receptor mismatch to enhance the antitumor efficacy of CAR-T cells.

Journal: Immunotherapy

Published: March 02, 2022

Showing 1-12 of 24

Last Updated: 09/26/2026